Shen DD - Search Results

1

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation.

Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB. Bearman SI, et al. Among authors: shen dd. Br J Haematol. 1993 Aug;84(4):724-30. doi: 10.1111/j.1365-2141.1993.tb03152.x. Br J Haematol. 1993. PMID: 8217833 Clinical Trial.

2

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.

Shen DD, Kunze KL, Thummel KE. Shen DD, et al. Adv Drug Deliv Rev. 1997 Sep 15;27(2-3):99-127. doi: 10.1016/s0169-409x(97)00039-2. Adv Drug Deliv Rev. 1997. PMID: 10837554

3

Use of glucosamine and chondroitin supplements and risk of colorectal cancer.

Kantor ED, Lampe JW, Peters U, Shen DD, Vaughan TL, White E. Kantor ED, et al. Among authors: shen dd. Cancer Causes Control. 2013 Jun;24(6):1137-46. doi: 10.1007/s10552-013-0192-2. Epub 2013 Mar 26. Cancer Causes Control. 2013. PMID: 23529472 Free PMC article.

4

Molecular insights into the activation mechanism of GPR156 in maintaining auditory function.

Ma X, Chen LN, Liao M, Zhang L, Xi K, Guo J, Shen C, Shen DD, Cai P, Shen Q, Qi J, Zhang H, Zang SK, Dong YJ, Miao L, Qin J, Ji SY, Li Y, Liu J, Mao C, Zhang Y, Chai R. Ma X, et al. Among authors: shen dd. Nat Commun. 2024 Dec 5;15(1):10601. doi: 10.1038/s41467-024-54681-5. Nat Commun. 2024. PMID: 39638804 Free PMC article.

5

Structural basis of orientated asymmetry in a mGlu heterodimer.

Huang W, Jin N, Guo J, Shen C, Xu C, Xi K, Bonhomme L, Quast RB, Shen DD, Qin J, Liu YR, Song Y, Gao Y, Margeat E, Rondard P, Pin JP, Zhang Y, Liu J. Huang W, et al. Among authors: shen dd. Nat Commun. 2024 Nov 28;15(1):10345. doi: 10.1038/s41467-024-54744-7. Nat Commun. 2024. PMID: 39609406 Free PMC article.

6

The mechanism of action and chemical synthesis of FDA newly approved drug molecules.

Shen DD, Zhang YL, Li X, Bai YR, Xiong JF, Seng DJ, Zhang YD, Liu HM, Yuan S, Yang L. Shen DD, et al. Drug Dev Res. 2024 Sep;85(6):e22260. doi: 10.1002/ddr.22260. Drug Dev Res. 2024. PMID: 39254376 Review.

7

The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.

Bai YR, Yang WG, Jia R, Sun JS, Shen DD, Liu HM, Yuan S. Bai YR, et al. Among authors: shen dd. Med Res Rev. 2025 Jan;45(1):214-273. doi: 10.1002/med.22069. Epub 2024 Aug 24. Med Res Rev. 2025. PMID: 39180380 Review.

8

Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers.

Mamun M, Zheng YC, Wang N, Wang B, Zhang Y, Pang JR, Shen DD, Liu HM, Gao Y. Mamun M, et al. Among authors: shen dd. Int Immunopharmacol. 2024 Aug 20;137:112355. doi: 10.1016/j.intimp.2024.112355. Epub 2024 Jun 8. Int Immunopharmacol. 2024. PMID: 38851158 Review.

9

Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs.

Shen Q, Tang X, Wen X, Cheng S, Xiao P, Zang SK, Shen DD, Jiang L, Zheng Y, Zhang H, Xu H, Mao C, Zhang M, Hu W, Sun JP, Zhang Y, Chen Z. Shen Q, et al. Among authors: shen dd. Adv Sci (Weinh). 2024 Jun;11(23):e2310120. doi: 10.1002/advs.202310120. Epub 2024 Apr 22. Adv Sci (Weinh). 2024. PMID: 38647423 Free PMC article.

10

Structure-based design of non-hypertrophic apelin receptor modulator.

Wang WW, Ji SY, Zhang W, Zhang J, Cai C, Hu R, Zang SK, Miao L, Xu H, Chen LN, Yang Z, Guo J, Qin J, Shen DD, Liang P, Zhang Y, Zhang Y. Wang WW, et al. Among authors: shen dd. Cell. 2024 Mar 14;187(6):1460-1475.e20. doi: 10.1016/j.cell.2024.02.004. Epub 2024 Feb 29. Cell. 2024. PMID: 38428423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters